Cancer Targeted Gene Panel Colon Colorectal Test
Test Cost: AED 2970.0
Symptoms, Diagnosis, and Referring Details
Test Name: CANCER TARGETED GENE PANEL COLON COLORECTAL Test
Components:
- Microsatellite Instability Panel
- KRAS
- BRAF
- PIK3CA
- PTEN
Price: 2970.0 AED
Sample Condition: Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Tissue block must contain at least 10% tumor tissue. Duly filled NGS Test Requisition Form is mandatory.
Report Delivery: Sample due by 9 am; Report within 10 working days
Method: Immunohistochemistry, NGS
Test Type: Cancer
Doctor: Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.
Test Details
The Cancer Targeted Gene Panel: Colon/Colorectal Test is a genetic test that analyzes specific genes associated with colon and colorectal cancer. It is used to identify mutations or alterations in these genes that may increase an individual’s risk of developing these types of cancer.
This test typically examines a panel of genes that are known to be involved in the development and progression of colon and colorectal cancer. These genes may include APC, KRAS, BRAF, PIK3CA, and others.
By analyzing these genes, the test can provide information about the presence of specific mutations or alterations that may be linked to an increased risk of developing colon or colorectal cancer.
The results of this test can help healthcare providers make more informed decisions regarding an individual’s risk of developing these types of cancer. It can also guide treatment options and provide valuable information for personalized medicine approaches.
It is important to note that this test is typically performed on individuals who have a personal or family history of colon or colorectal cancer, or those who have other risk factors for these types of cancer. It is not a screening test for the general population.
As with any genetic test, it is recommended to discuss the potential benefits, limitations, and implications of the test with a healthcare provider or genetic counselor before undergoing testing.
Test Name | CANCER TARGETED GENE PANEL COLON COLORECTAL Test |
---|---|
Components | *Microsatellite Instability Panel *KRAS*BRAF*PIK3CA*PTEN |
Price | 2970.0 AED |
Sample Condition | Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature.Tissue block must contain at least 10% tumor tissue. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample Tue by 9 am; Report 10 Workingdays |
Method | Immunohistochemistry, NGS |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details |
The Cancer Targeted Gene Panel: Colon/Colorectal Test is a genetic test that analyzes specific genes associated with colon and colorectal cancer. It is used to identify mutations or alterations in these genes that may increase an individual’s risk of developing these types of cancer. This test typically examines a panel of genes that are known to be involved in the development and progression of colon and colorectal cancer. These genes may include APC, KRAS, BRAF, PIK3CA, and others. By analyzing these genes, the test can provide information about the presence of specific mutations or alterations that may be linked to an increased risk of developing colon or colorectal cancer. The results of this test can help healthcare providers make more informed decisions regarding an individual’s risk of developing these types of cancer. It can also guide treatment options and provide valuable information for personalized medicine approaches. It is important to note that this test is typically performed on individuals who have a personal or family history of colon or colorectal cancer, or those who have other risk factors for these types of cancer. It is not a screening test for the general population. As with any genetic test, it is recommended to discuss the potential benefits, limitations, and implications of the test with a healthcare provider or genetic counselor before undergoing testing. |